![](https://pharmaphorum.com/sites/default/files/2024-07/Merdad_Parsey.jpeg)
Merdad Parsey will leave Gilead next year
Gilead Sciences' chief medical officer, Merdad Parsey, will leave the company in early 2025, becoming the latest in a series of high-profile departures involving senior R&D figures at top drugmakers. Parsey, who is in charge of the company's …